EGY

(4R,7R)-4-hydroxy-N,N,N-trimethyl-4,9-dioxo-7-[(undecanoyloxy)methyl]-3,5,8-trioxa-4lambda~5~-phosphadocosan-1-aminium

Created:	2018-01-10
Last modified:	2018-01-31

Find Related PDB Entry
4 entries where EGY is found as a standalone ligand1 entries where EGY is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	1
Atom Count	110
Chiral Atom Count	1
Bond Count	109
Aromatic Bond Count	0

2D diagram of EGY

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(4R,7R)-4-hydroxy-N,N,N-trimethyl-4,9-dioxo-7-[(undecanoyloxy)methyl]-3,5,8-trioxa-4lambda~5~-phosphadocosan-1-aminium
Systematic Name (OpenEye OEToolkits)	trimethyl-[2-[oxidanyl-[(2~{R})-2-tetradecanoyloxy-3-undecanoyloxy-propoxy]phosphoryl]oxyethyl]azanium
Formula	C₃₃ H₆₇ N O₈ P
Molecular Weight	636.861
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	OP(=O)(OCC[N+](C)(C)C)OCC(COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCCCC
SMILES	CACTVS	3.385	CCCCCCCCCCCCCC(=O)O[CH](COC(=O)CCCCCCCCCC)CO[P](O)(=O)OCC[N+](C)(C)C
SMILES	OpenEye OEToolkits	2.0.6	CCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCC)COP(=O)(O)OCC[N+](C)(C)C
Canonical SMILES	CACTVS	3.385	CCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCC)CO[P](O)(=O)OCC[N+](C)(C)C
Canonical SMILES	OpenEye OEToolkits	2.0.6	CCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCC)COP(=O)(O)OCC[N+](C)(C)C
InChI	InChI	1.03	InChI=1S/C33H66NO8P/c1-6-8-10-12-14-16-17-18-20-22-24-26-33(36)42-31(30-41-43(37,38)40-28-27-34(3,4)5)29-39-32(35)25-23-21-19-15-13-11-9-7-2/h31H,6-30H2,1-5H3/p+1/t31-/m1/s1
InChIKey	InChI	1.03	GGHWXDCJHDYMKO-WJOKGBTCSA-O

Related Resource References

Resource Name	Reference
PubChem	71305049

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.